Indianapolis, IN, United States of America

Melissa L Fishel

This inventor holds 6 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Indiana University, University of Toronto, Uti Limited Partnership. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melissa L Fishel. Retrieved from https://idiyas.com/inventor/melissa-l-fishel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 83.3

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Indianapolis, IN (US) (2016 - 2019)
Fishers, IN (US) (2020 - 2023)

Company Filing History:

University of Toronto

patents

2 out of 140

Uti Limited Partnership

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12350247 - Use of APE1/Ref-1 inhibitors for treatment of retinal diseases (2025-07-08),

2. 11648226 - Use of APE1/Ref-1 inhibitors for treatment of retinal diseases (2023-05-16),

3. 10772859 - Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genes (2020-09-15),

4. 10377780 - Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof (2019-08-13),

5. 9650399 - Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof (2017-05-16),

6. 9315481 - Compounds and methods for treating leukemia (2016-04-19),

Title: Innovations by Melissa L Fishel

Introduction

Melissa L Fishel is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of medical research, particularly in the treatment of retinal diseases and cancers. With a total of six patents to her name, her work has the potential to impact many lives.

Latest Patents

Among her latest patents is the use of APE1/Ref-1 inhibitors for the treatment of retinal diseases. This patent details combination therapies that include an Apurinic/Apyrimidinic Endonuclease/reduction-oxidation (redox) Factor-1 (APE1/Ref-1) inhibitor. The focus is on inhibiting the redox function of APE1/Ref-1, which can be utilized in treating various cancers and other angiogenesis-mediated diseases, such as retinal and cardiovascular diseases.

Career Highlights

Melissa has worked with esteemed institutions, including Indiana University and the University of Toronto. Her research has garnered attention for its innovative approach to addressing complex medical challenges.

Collaborations

Some of her notable coworkers include Mark R Kelley and Patrick Thomas Gunning. Their collaborative efforts have contributed to the advancement of research in their respective fields.

Conclusion

Melissa L Fishel's work exemplifies the spirit of innovation in medical research. Her patents and collaborations highlight her commitment to improving treatment options for serious health conditions.

Profile summary based on public USPTO records.